Literature DB >> 15245746

New models for the study of Mycobacterium-host interactions.

Tamara C Pozos1, Lalita Ramakrishnan, Lalita Ramakrishan.   

Abstract

The outcome of Mycobacterium infection is determined by a series of complex interactions between the bacteria and host immunity. Traditionally, mammalian models and cultured cells have been used to study these interactions. Recently, ameba (Dictyostelium), fruit flies (Drosophila) and zebrafish, amenable to forward genetic screens, have been developed as models for mycobacterial pathogenesis. Infection of these hosts with mycobacteria has allowed the dissection of intracellular trafficking pathways (Dictyostelium) and the roles of phagocytic versus antimicrobial peptide responses (Drosophila). Real-time visualization of the optically transparent zebrafish embryo/larva has elucidated mechanisms by which Mycobacterium-infected leukocytes migrate and subsequently aggregate into granulomas, the hallmark pathological structures of tuberculosis.

Entities:  

Mesh:

Year:  2004        PMID: 15245746     DOI: 10.1016/j.coi.2004.05.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  32 in total

Review 1.  Perspectives on antigen presenting cells in zebrafish.

Authors:  Kanako L Lewis; Natasha Del Cid; David Traver
Journal:  Dev Comp Immunol       Date:  2014-03-29       Impact factor: 3.636

2.  Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish.

Authors:  Hilary Clay; J Muse Davis; Dana Beery; Anna Huttenlocher; Susan E Lyons; Lalita Ramakrishnan
Journal:  Cell Host Microbe       Date:  2007-07-12       Impact factor: 21.023

3.  Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.

Authors:  Elizabeth Fullam; Akane Kawamura; Helen Wilkinson; Areej Abuhammad; Isaac Westwood; Edith Sim
Journal:  Protein J       Date:  2009-08       Impact factor: 2.371

4.  Sporulation in mycobacteria.

Authors:  Jaydip Ghosh; Pontus Larsson; Bhupender Singh; B M Fredrik Pettersson; Nurul M Islam; Sailendra Nath Sarkar; Santanu Dasgupta; Leif A Kirsebom
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

Review 5.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

6.  A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.

Authors:  Rachel E Bosserman; Kathleen R Nicholson; Matthew M Champion; Patricia A Champion
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

8.  Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization.

Authors:  Melanie J Harriff; Martin Wu; Michael L Kent; Luiz E Bermudez
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

9.  Host-detrimental role of Esx-1-mediated inflammasome activation in mycobacterial infection.

Authors:  Fredric Carlsson; Janice Kim; Calin Dumitru; Kai H Barck; Richard A D Carano; Mei Sun; Lauri Diehl; Eric J Brown
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

10.  Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta.

Authors:  Stefanie Kunz; Karin Oberle; Anna Sander; Christian Bogdan; Ulrike Schleicher
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.